Stage II HR-Positive Invasive Ductal Carcinoma: Doreen's Patient Story
This breast cancer diagnosis at a glance
- Stage at diagnosis
- Stage II
- Subtype
- Invasive Ductal Carcinoma
- Biomarkers
- ER-positive; PR-positive; HER2-positive
- Sex
- Female
- Treatment
- chemotherapy, surgery, radiation and antibody therapy
- Outcome
- Responding Well
Treatment course, step by step
- Stage IIA triple-positive breast cancer diagnosed after a left breast lump; tumor about 2-3 cm, lymph nodes initially checked as not involved
- MRI, echocardiogram, port placement, and oncology consultation within about 1 week
- neoadjuvant TCHP chemotherapy through a port, with Taxotere given first and infusions lasting about 4.5 hours every 3 weeks; side effects included nausea, diarrhea, sore throat, taste loss, hair loss, fatigue, and cognitive effects
- complete response before surgery, with the lump no longer found on preoperative evaluation
- guided-wire biopsy/lymph-node mapping before surgery
- lumpectomy and radiation therapy described in the story summary.
What happened, in summary
Doreen was diagnosed with Stage IIA triple-positive invasive ductal breast cancer after finding a lump in her left breast during a work trip. Getting the right imaging took persistence: after several calls and one wrong order, she finally had the correct mammogram and ultrasound, followed by a core biopsy the next day. Early testing showed a 2 to 3 cm tumor and no lymph-node involvement on initial checks. The diagnosis came just as she was leaving for a friend’s wedding in Italy, so she carried the fear quietly until she returned and met with a patient advocate. Within about 1 week, she had a surgery consult, MRI, echocardiogram, port placement, and oncology visit. Chemotherapy became part of the plan because the cancer was triple-positive. Doreen received neoadjuvant TCHP through her port, with Taxotere given first and infusions lasting about 4.5 hours every 3 weeks. She worked through treatment when she could, while managing nausea, diarrhea, sore throat, taste loss, hair loss, fatigue, and chemo brain. By the time she was ready for surgery, chemotherapy had produced a complete response: the lump could no longer be found. As of June 2026, she had also undergone lumpectomy and radiation and was describing recovery with humor and strong support.
Where this story comes from
This is a lay summary of an account first published by The Patient Story. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer